HDAC9 and breast cancer: Several types of HDAC inhibitors have been exploited to suppress the effect of HDAC on breast cancer antiestrogen resistance.[41, 42] Here, we found that DNA hypermethylation and histone deacetylation cause MIR497HG repression.